NKT1 is antitumor, while NKT2 is primarily tumor-promoting.IL-13 produced by NKT2 induces MDSC to produce TGF-β, which inhibits the anti-tumor immune response mediated by CD8+T cells (63). The gene discussed is IL13; the disease is neoplasm.